Consumer Test Reveals Major Discrepancies Among Top Cat DNA Kits

An independent journalist collected saliva samples from two house cats, sent them to three of the most heavily promoted feline DNA testing services, and found that each company delivered markedly different breed and health profiles.

Pet genetic testing has shifted from a niche curiosity to a mainstream commodity, as owners seek insight into breed ancestry, possible health risks, and even personality traits. While DNA kits for dogs have been on the market for years, cat‑specific options are relatively recent, raising questions about their reliability.

For the test, the cat owner swabbed the mouths of both animals, packaged the specimens according to each provider’s guidelines, and mailed them to the respective labs. All three firms rely on proprietary genotyping arrays that examine a set number of genetic markers before producing a digital report that lists breed composition, detected mutations, and risk assessments for certain conditions.

The three reports varied widely. One service identified a strong Siamese lineage in the tabby cat, another labeled it chiefly as mixed domestic, and the third presented a mixture of several breeds with low confidence. Health‑related findings also differed: a predisposition to hypertrophic cardiomyopathy appeared in one analysis but was missing from the other two, which instead flagged possible food sensitivities.

Analysts attribute the inconsistency to the absence of standardized reference databases and to differing counts of genetic markers. Without a universal benchmark, each company’s algorithm interprets the same raw data in its own way, producing contradictory conclusions. Moreover, many complex traits—such as behavior or disease susceptibility—are governed by multiple genes and environmental influences, limiting the predictive power of any single test.

Consumer‑advocacy groups recommend that pet owners view DNA test outcomes as an initial screening tool rather than a definitive diagnosis. Veterinarians can help interpret any flagged health concerns and decide whether additional clinical testing is needed. As the market grows, the price of kits—generally ranging from $80 to $150—must be balanced against the practical value of the information supplied.

Looking forward, several providers have announced intentions to expand their genetic panels, add more breeds, and refine their analytical models. Yet regulatory oversight remains limited, and no industry‑wide standards have been set. Ongoing consumer interest is likely to spur competition and calls for greater transparency, which could ultimately enhance the accuracy and usefulness of feline DNA testing for owners and veterinarians alike.